Human Intestinal Organoid
Human Intestinal Organoids are three-dimensional (3D) multicellular structures generated in vitro from adult stem cells or pluripotent stem cells. They exhibit polarity and recapitulate, to a significant extent, the structure and function of real organs. Human Small Intestine Organoid model developed by Cytrix is derived from normal human intestinal stem cells and demonstrates robust self-organization, long-term growth, and renewal capacity. It contains multiple types of mature intestinal epithelial cells. Under light microscopy, the organoids typically appear as cystic or budding structures with a central lumen surrounded by tightly arranged columnar epithelial cells. The lumen and its interface with the external environment are sharply defined, while the cells appear bright and transparent, displaying characteristic morphology. Organoids are rigorously tested for mycoplasma, bacteria, fungi/yeast, and are verified for identity, genetic stability, and functional performance.
Specifications
- rank math seo score
- 4
- rank math contentai score
- a:5:{s:8:"keywords";s:5:"74.51";s:9:"wordCount";s:1:"0";s:9:"linkCount";s:1:"0";s:12:"headingCount";s:1:"0";s:10:"mediaCount";s:1:"0";}
- product code
- Human Intestinal Organoid; HIO; Human Intestinal 3D Culture
- cat no
- C-087
- disease
- Normal
- organism
- Human
- tissue
- Intestinal
- growth properties
- Embedded 3D Culture
- biosafety level
- 1
- growth conditions
- 37℃, 95% Air, 5% CO 2
- size quantity
- 1
- product format
- Frozen
- shipping info
- Dry Ice
- storage conditions
- Liquid Nitrogen
- quality control
- All test negative for mycoplasma, bacteria, yeast, and fungi.
- application
- For research use only. Intestinal organoids provide physiologically relevant models that overcome the limitations of traditional epithelial-only systems. Optimized for preclinical small-animal studies, they enable advanced research in intestinal development, inflammation, cancer, drug discovery, barrier function, neuro–immune regulation, and regenerative medicine, offering powerful tools for both basic research and therapeutic innovation.